TRDA
Entrada Therapeutics Inc

166
Loading...
Loading...
Upcoming Earnings: Q3 '25
Reports: Nov 04,
Pre-Market

Estimated EPS

-$0.99

Estimated Rev

$7.03M

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '25
-$0.99
--
--
N/A
Q2 '25
-$0.85
-$1.04
-22.76%
MISSED
Q1 '25
-$0.79
-$0.42
46.74%
BEAT
Q4 '24
-$0.67
$0.03
104.48%
BEAT
Q3 '24
-$0.73
-$0.35
51.92%
BEAT

Latest TRDA News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.